GE HealthCare taps Enlitic for large-scale imaging data migration plans

GE HealthCare is turning to the imaging data analytics specialists at Enlitic to tackle its large-scale data migration needs. 

The duo announced the partnership on Monday, stating that the collaboration marks “a shift in how healthcare institutions approach data.” 

“We are moving beyond conventional migrations, enabling healthcare providers to move to the cloud with confidence,” Michael Sistenich, CEO of Enlitic, said in the announcement. “By leveraging AI and automation, we will set a new standard in enterprise imaging that will ensure data is not only transferred but transformed into a strategic asset. Healthcare providers deserve solutions that do not just keep up but lead the way forward.” 

Enlitic and its subsidiary Laitek will utilize the latter’s artificial intelligence-enabled data migration technology to streamline the transition of GE customers’ legacy archiving systems to the company’s newer enterprise imaging and PACS solutions, like Datalogue and True PACS. Enlitic’s Ensight Suite ensures that the data will be standardized, cohesive and in compliance with all applicable global regulations, regardless of the imaging platform it originated from. 

Embedded with AI, Ensight Suite’s automated tools can structure and optimize the data being transitioned to the cloud, making it much easier for users to access the information they need without having to conduct multiple searches for a single exam or patient. This not only benefits providers in clinical practice, but also researchers, saving both time and money. 

“Our collaboration with Enlitic is not just about efficiency—it is about revolutionizing how healthcare providers access, analyze, and act on their data,” said Scott Miller, CEO of Solutions for Enterprise Imaging at GE HealthCare. “We are bridging the gap between legacy systems and the future of AI-powered healthcare, ensuring our customers are always ahead of the curve.” 

Learn more about the partnership here. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.